Kazia Therapeutics Announces $2.0 Million Registered Direct Offering

PR NewswireJan 10 22:58

Sector Update: Health Care Stocks Lower in Afternoon Trading

MT NewswiresJan 1 02:51

Why Is Brain Cancer-Focused Kazia Therapeutics Stock Trading Lower On Tuesday?

BenzingaJan 1 01:34

Kazia Therapeutics Charts Path Forward for Paxalisib After FDA Feedback

TipRanksDec 31, 2024 21:57

Kazia Therapeutics Shares Drop After FDA Derails Fast Track of Potential Brain Cancer Drug

MT NewswiresDec 31, 2024 21:44

Kazia Says It Evaluates Next Steps In NDU Glioblastoma; Believes Paxalisib Shows Potential To Be Evaluated In Breast Cancers

BenzingaDec 31, 2024 21:08